As the unknown metabolite antigen or antigens presented by MR1 are specific to or associated with cancer, they may represent a novel class of neoantigens, beyond the neo-peptides arising from altered tumor proteins and presented by classical MHC-I or MHC-II. Here, MR1 is linked to cancer.